Testing Status of Agents at NTP
Indium phosphide
CASRN: 22398-80-7
Formula: IN-P
Known Uses:
USED IN ELECTRONICS INDUSTRY; IN SEMICONDUCTOR DEVICES, INJECTOR LASERS, AND SOLAR CELLS. PROPOSED TO REPLACE SILICON IN COMPUTER MICROCHIPS.
Nomination Background
Short-Term Toxicity
- 3-DAY (Inhalation)
(C88124) Completed
- NTIS No. PB2002-100069
(Peer Review 05/18/2000)
Citation: Toxicology and Carcinogenesis Studies of Indium Phosphide (CAS No. 22398-80-7) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) - Rats: F344/N; Mice: B6C3F1
- Dose: R&M: 100 OR 300 MG/M3; 10/SEX/GROUP (NOSE ONLY)
- NTIS No. PB2002-100069
(Peer Review 05/18/2000)
- 13-WEEK (Inhalation)
(C88124) Completed
- NTIS No. PB2002-100069
(Peer Review 05/18/2000)
Citation: Toxicology and Carcinogenesis Studies of Indium Phosphide (CAS No. 22398-80-7) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) - Rats: F344/N; Mice: B6C3F1
- Dose: R&M: 0, 1, 3, 10, 30, OR 100 MG/M3; 10/SEX/GROUP
- NTIS No. PB2002-100069
(Peer Review 05/18/2000)
Long-Term Carcinogenicity
- 2-YEAR (Inhalation)
(C88124) Report Complete
- TR-499 (NTIS No. PB2002-100069)
(Peer Review 05/18/2000)
Toxicology and Carcinogenesis Studies of Indium Phosphide (CAS No. 22398-80-7) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) - Rats: F344/N; Mice: B6C3F1
- Carcinogenesis Results
- Male Rats Clear Evidence
- Female Rats Clear Evidence
- Male Mice Clear Evidence
- Female Mice Clear Evidence
- Dose: R&M: 0, 0.03, 0.1, OR 0.3 MG/M3
- TR-499 (NTIS No. PB2002-100069)
(Peer Review 05/18/2000)
Special Studies
- Absorption Disposition Metabolism Elimination (Gavage)
(S0260) Completed
- M Rats: F344/N
- Dose: 10 MG/KG
Genetic Toxicology
- Micronucleus
(A49283) Completed
- Mice: B6C3F1
- Male Negative
- Female Negative
Web page last updated on January 22, 2009